Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
160M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
47.2M
-
Shares change
-
-298K
-
Total reported value, excl. options
-
$354M
-
Value change
-
-$5.66M
-
Number of buys
-
29
-
Number of sells
-
-38
-
Price
-
$7.49
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) as of Q1 2022
90 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value as of Q1 2022.
Cogent Biosciences, Inc. - Common Stock, $0.001 par value (COGT) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.2M shares
of 160M outstanding shares and own 29.44% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (3.9M shares), COMMODORE CAPITAL LP (3.5M shares), PERCEPTIVE ADVISORS LLC (3.19M shares), JANUS HENDERSON GROUP PLC (3.17M shares), TCG Crossover Management, LLC (2.98M shares), Frazier Life Sciences Management, L.P. (2.65M shares), BlackRock Inc. (2.64M shares), Vivo Capital, LLC (1.92M shares), Candriam Luxembourg S.C.A. (1.75M shares), and Ghost Tree Capital, LLC (1.7M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.